Activation of bovine factor IX by the reaction product of bovine factor VII and human tissue factor.
A study was carried out on the alternate activation of factor IX (FIX) by bovine FVII and human tissue factor (TF) rather than by activated factor XI (FXIa). The reaction product of bovine FVII and human TF functioned as a FIX activator in the assay system used. Published studies suggest that in the presence of Ca2+ ions, the complex of human FVII-TF readily activates both human FIX and human FX, and at low TF concentrations, FIX appears to be the preferred substrate for the reaction product of FVII and TF. This may explain the discrepancy between the mild bleeding of hereditary FXI deficiency and the severe bleeding of hereditary FIX deficiency. The results obtained with bovine FVII and a crude human TF preparation confirm that at low TF concentrations, bovine FIX is the preferred substrate rather than FX. At higher TF concentrations, bovine FX was rapidly activated.
Liu
D Y
DY
National Institute for the Control of Pharmaceutical and Biological Products, Beijing, P.R. China.
Rosen
S
S
D000818:Animals; D002417:Cattle; D005164:Factor IX / Q000378:metabolism*; D015949:Factor IXa / Q000096:biosynthesis; D005167:Factor VII / Q000494:pharmacology*; D005170:Factor X / Q000378:metabolism; D015951:Factor Xa / Q000096:biosynthesis; D006801:Humans; D013925:Thromboplastin / Q000494:pharmacology*
D005167:Factor VII; D005164:Factor IX; D005170:Factor X; D013925:Thromboplastin; D015949:Factor IXa; D015951:Factor Xa